Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
about
Design and pre-clinical evaluation of a universal HIV-1 vaccineMolecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitisFull-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombinationHIV-1 Vaccine Trials: Evolving Concepts and DesignsA comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in AfricaMolecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from BotswanaHuman immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition.Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaquesRole of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in MacaquesMulticlade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys.Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA allelesIdentification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designCross-reactive potential of human T-lymphocyte responses in HIV-1 infectionBroad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 allelesMagnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responsesProtection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid.T cell cross-reactivity and conformational changes during TCR engagement.An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort.Advances in FIV vaccine technology.Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control
P2860
Q21092234-8AC89E8C-B7D9-4896-9D15-7CA60BAEDB0AQ27469459-08029712-E1C0-422D-A3E0-4E78DFDB0671Q29616724-E7FD8A7F-92EE-4BE1-B59E-D6A119BA8093Q30425520-E1D5F39B-D1C7-41A3-BC36-7F48A9BB5F1FQ30430708-DD2495CA-89B3-46A5-8662-05FCDA4AB53DQ33642531-BE33AC18-0205-44AD-A961-3E45C81CC564Q33648343-71F3A6B3-E75B-4735-96BA-90F4CFFED9E8Q33707543-EA57068F-9B45-4A9E-A022-0BE75B04C0C9Q33810425-3F40FD24-3A89-4CBD-8CDB-1CD22C8EE04CQ33819493-B6DFD58A-C9AB-4EA4-95CB-D096E4C23F8CQ33834916-B6311EDE-A4B4-4CFD-9E38-9F5D1B0FFD99Q33839981-CD24023E-3A75-405A-95B5-0E7ECB1A5870Q33842771-62ABA645-08C5-40CC-ACB6-007FD8AC97F5Q33845527-ECBCF95F-A975-466F-A398-6487F454DA28Q33855306-C41F6584-5B55-475E-8998-C7B684D5EDA8Q33930297-91930588-B96B-4E40-93EF-57759C88D63FQ34332009-17978E25-F333-492A-9EB6-A752E93A4645Q34339044-2CDC52D0-85A1-487F-AD38-545CE5143563Q34348269-CB42CB6D-3548-4C33-83C5-48D9B0A5625CQ34358831-29DDB167-9D2C-4F1E-B5C3-C121C0C98A0AQ34362699-ED809233-028D-4D77-8744-9B03FD753B1CQ34364357-D8B30C63-2ECF-49F2-B587-D9BB270AA2F8Q35044067-BC659CB4-BF96-4A34-9A83-C58D910A0CE3Q36276936-D04DFFB1-C6E1-4EDD-B387-8A9249BB1648Q36399643-5A611B2B-5A2F-4130-9091-8B4A9CC475BFQ36483367-61616729-BD07-4384-A29E-16D42AF53F14Q36634847-668F6A02-50EB-46E4-ADEC-371873CA6CD7Q36909497-B3F71B0D-FEF9-4A7D-BE50-7CF2B05B9DD3Q37235277-7DAC505A-C9A8-47FA-8E9C-2C84DA9A1666Q37387851-24F3B1FC-9C9E-45F1-A4D8-F4056BFF5707Q39602888-C3883494-4188-45C1-80B8-60CD1B067729Q40165296-F54B28BB-E516-4B0A-8A7A-5AE6005E4833Q58702145-A40EC140-2031-4941-80D8-82606924AD8C
P2860
Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Cytotoxic T-lymphocyte cross-r ...... tions for vaccine development.
@ast
Cytotoxic T-lymphocyte cross-r ...... tions for vaccine development.
@en
type
label
Cytotoxic T-lymphocyte cross-r ...... tions for vaccine development.
@ast
Cytotoxic T-lymphocyte cross-r ...... tions for vaccine development.
@en
prefLabel
Cytotoxic T-lymphocyte cross-r ...... tions for vaccine development.
@ast
Cytotoxic T-lymphocyte cross-r ...... tions for vaccine development.
@en
P2093
P2860
P1433
P1476
Cytotoxic T-lymphocyte cross-r ...... tions for vaccine development.
@en
P2093
A Dieng-Sarr
B D Walker
G P Mazzara
J L Sankalé
S A Kalams
P2860
P304
P407
P50
P577
1997-11-01T00:00:00Z